Douglas Fleming

9.9k citations
168 papers · 8.3k · 1 hit paper · h-index 50

Impact in

  • Epidemiology top 0.2%
    • Influenza Virus Research Studies
    • Respiratory viral infections research
    • Herpesvirus Infections and Treatments
    • Data-Driven Disease Surveillance
    • Pneumonia and Respiratory Infections
    • Antibiotic Use and Resistance

Papers in

    • Influenza Virus Research Studies 73
    • Respiratory viral infections research 8
    • Data-Driven Disease Surveillance 8
    • Chronic Disease Management Strategies 7
    • Herpesvirus Infections and Treatments 5
    • Primary Care and Health Outcomes 32

Douglas Fleming

164 papers receiving 7.5k citations

Douglas Fleming's Hit Papers

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections 1997 · 618 citations
6180+9+19Years since publication200400600

Peers

Douglas Fleming
Comparison fields: 5 of 158
  • Epidemiology 5k
  • Applied Microbiology and Biotechnology 238
  • Immunology and Allergy 164
  • General Health Professions 530
  • Health 214
Replace Edward F. Mitchel with:
Edward F. Mitchel United States
Eelko Hak Netherlands
Tina V. Hartert United States
Jonathan A. Finkelstein United States
Cameron Charles Grant New Zealand
Shinn‐Jang Hwang Taiwan
Rosalind Louise Smyth United Kingdom
Stephen C. Redd United States
Bruce C. Marshall United States
Jay S. Steingrub United States
Douglas Fleming relative to Edward F. Mitchel United States Edward F. Mitchel's profile →
Citations per field
00.5×2×3×3.8×
Edward F. Mitchel · 1×
Citations per year

Countries citing papers authored by Douglas Fleming

Since Specialization
Citations

This map shows the geographic impact of Douglas Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Fleming more than expected).

Fields of papers citing papers by Douglas Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Fleming. The network helps show where Douglas Fleming may publish in the future.

Co-authors

The 25 scholars most cited alongside Douglas Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas Fleming Line = papers co-authored together Douglas Fleming links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
Hit paper breakdown →
1997618
2 2013357
3 1987337
4 2002249
5 1999235
6 2006230
7 2013203
8 2005183
9 2015181
10
Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases.
2007157
11 2000148
12 1997146
13 2006144
14 2013138
15 2014133
16
The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter.
2000130
17 2004127
18 2000116
19 2002116
20
Service profiles of general practitioners in Europe. European GP Task Profile Study.
1997114

About Douglas Fleming

Douglas Fleming is a scholar working on Epidemiology, General Health Professions, Health Information Management, Applied Microbiology and Biotechnology and Geriatrics and Gerontology, having authored 168 papers that have together received 8.3k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (73 papers), Primary Care and Health Outcomes (32 papers), Asthma and respiratory diseases (9 papers), Respiratory viral infections research (8 papers), Data-Driven Disease Surveillance (8 papers), Chronic Disease Management Strategies (7 papers), Antibiotic Use and Resistance (6 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Epidemiology (5k citations), Applied Microbiology and Biotechnology (238 citations), Immunology and Allergy (164 citations), General Health Professions (530 citations) and Health (214 citations). Douglas Fleming has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Donald L. Crombie, Maria Cristina Fleischmann Alves Zambon, Alex James Elliot, K. W. Cross, Oliver N. Keene, Kenneth W. Cross, Joanna Ellis, Roger L. Lustig, Robert J. Taylor and William John Paget. Their work appears in journals such as Epidemiology and Infection, European Journal of General Practice, Vaccine, Eurosurveillance and Journal of Epidemiology & Community Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact